Entera Bio Ltd.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.3M | $-3.5M | $-3.0M | $-3.2M | $-2.7M | $-2.6M | $-2.4M | $-3.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $9.0K | $7.0K | $7.0K | $8.0K | $7.0K | $8.0K | $11.0K | $11.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $624.0K | $672.0K | $710.0K | $927.0K | $509.0K | $604.0K | $566.0K | $928.0K |
| Net Cash from Operating Activities | $-3.5M | $-3.1M | $-1.8M | $-2.5M | $-1.6M | $-1.4M | $-1.5M | $-2.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.0K | $0 | $27.0K | $43.0K | $29.0K | $8.0K | $3.0K | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-3.0K | $0 | $-27.0K | $-43.0K | $-29.0K | $-8.0K | $-3.0K | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.0M | $130.0K | $174.0K | $250.0K | $-51.0K | $13.3M | $3.2M | $13.0K |
| Net Change in Cash | — | — | — | — | $-1.7M | $11.9M | $1.7M | $-2.1M |
| Free Cash Flow | $-3.5M | $-3.1M | $-1.9M | $-2.5M | $-1.7M | $-1.4M | $-1.5M | $-2.2M |